
11.71 Delayed Data As of Jun 09 | ![]() Today’s Change | 6.88 Today|||52-Week Range 22.87 | +26.87% Year-to-Date |
The 10 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 26.00, with a high estimate of 35.00 and a low estimate of 12.00. The median estimate represents a +122.03% increase from the last price of 11.71.
The current consensus among 11 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.